Shilpa Grover, MD; Matthew J. Hamilton , MD; David L. Carr-Locke MD, FRCP, FACG, FASGE Series Editor: David L. Carr-Locke MD, FRCP, FACG, FASGE


May 29, 2007


Given the increased incidence and severity of C difficile infections and the emergence of a highly virulent strain, prevention of CDAD by judicious use of antibiotics and infection control is of critical importance. The role of newer agents in this setting remains to be defined. Immunotherapy with pooled immune globulin may help avert surgery in patients with refractory CDAD.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: